Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Spike glycoprotein inhibitor | FDA |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4650488 |
CONTENTS